About 120 years ago, small towns argued over roads. Horses and bicycles were how we traveled. Some crazies thought horseless ...

Catch up on the latest trends in health news in this roundup of long-reads compiled by Live Science's health channel editor.

Researchers are edging closer to something long imagined but never quite within reach: a single vaccine platform that could be adapted to fight many kinds of cancer. Early experiments in animals and ...

Get the latest Moderna (MRNA) stock analysis: balanced risk-reward, new vaccine launches, and pipeline insights. See why we ...

Moderna and Alnylam are investing millions in Massachusetts biomanufacturing, a rare win for a state often losing the ...

Peptides are short chains of amino acids. They arrive as powders labelled “for research use only,” are mixed at home with ...

With President Donald Trump back in the White House in 2025, it’s no surprise that he dominates the FactCheck.org year-end ...

The Federal Government has trained scientists drawn from key research institutions across the country on mRNA technology ...

Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and ...

Stéphane Bancel, Moderna’s founding chief executive, has sold his six-level Beacon Hill townhouse after owning in the ...

A Stanford-led study probes why a very small number of people develop heart inflammation shortly after mRNA COVID-19 ...

Moderna, Inc. has rallied ~23%, but rated a Sell due to deteriorating fundamentals. Learn more about MRNA stock here.